SOURCE: Industrial Info Resources

Industrial Info Resources

September 17, 2010 05:30 ET

Who Knew? Pharmaceutical-Biotech Industry Planning 200 New North American Sites With $14.4 Billion Investment, an Industrial Info News Alert

SUGAR LAND, TX--(Marketwire - September 17, 2010) -  Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- As the third quarter winds to an end and no definitive answers are available as to when the roller coaster ride of the Pharmaceutical-Biotech Industry will finally hit the steady rail up, it is as good of a time as any to take a look at new-build activity. In North America alone, the industry has 200 sites being actively developed. All are in various stages, from early planning to construction, and represent a potential $14.4 billion in capital investment, according to Industrial Info's Pharmaceutical Tracker - Online Database. One of the current jewels of the industry is Shire plc's (NASDAQ:SHPGY) $394 million first-phase Human Genetic Therapies manufacturing plant in Lexington, Massachusetts. 

For details, view the entire article by subscribing to Industrial Info's Premium Industry News at, or browse other breaking industrial news stories at

Industrial Info Resources (IIR) is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. IIR's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. For more information send inquiries to or visit us at

Follow us on: Facebook - Twitter - LinkedIn - Vimeo